The Misuse of Drugs (Designation) (Amendment No.2) Order (Northern Ireland) 2014

Amendment of the Misuse of Drugs (Designation) Order 2001

2.  In Part 1 of the Schedule to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 (1) (controlled drugs to which section 7(4) of the Misuse of Drugs Act applies), after paragraph 1(t) insert—

“(u) Any compound (not being benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from mescaline, 4-bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-dimethoxy-α,4-dimethylphenethylamine, N-hydroxytenamphetamine, or a compound specified in sub-paragraph (c) or (d) above by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.

(v) Any compound (not being a compound for the time being specified in sub-paragraph (c) above) structurally derived from 1-benzofuran, 2,3-dihydro-1-benzofuran, 1H-indole, indoline, 1H-indene, or indane by substitution in the 6-membered ring with a 2-ethylamino substituent whether or not further substituted in the ring system to any extent with alkyl, alkoxy, halide or haloalkyl substituents and whether or not substituted in the ethylamino side-chain with one or more alkyl substituents.”

(1)

S.R. 2001 No.431 relevant amending Orders are S.R. 2014 No.20, S.R. 2013 No.77, S.R. 2012 No.212, S.R. 2011 No.154, S.R. 2010 No.149 and No.246, S.R. 2009 No.389 and S.R. 2005 No.359